Fred Alger Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-550
| Closed | -$125K | – | 535 |
|
|
2020
Q1 | $125K | Sell |
550
-50
| -8% | -$11.4K | ﹤0.01% | 405 |
|
|
2019
Q4 | $317K | Hold |
600
| – | – | ﹤0.01% | 402 |
|
|
2019
Q3 | $259K | Buy |
600
+200
| +50% | +$86.3K | ﹤0.01% | 397 |
|
|
2019
Q2 | $477K | Buy |
+400
| New | +$477K | ﹤0.01% | 384 |
|
|
2018
Q2 | – | Sell |
-70
| Closed | -$114K | – | 558 |
|
|
2018
Q1 | $114K | Buy |
70
+50
| +250% | +$81.4K | ﹤0.01% | 404 |
|
|
2017
Q4 | $34K | Buy |
+20
| New | +$34K | ﹤0.01% | 442 |
|